[ad_1] New drugs to defeat “superbug” bacteria aren’t reaching patients. [ad_2] Source link
Tag: Sarepta Therapeutics
New Gene Therapy Could Face Uphill Battle Despite FDA Approval
[ad_1] The FDA approval of BioMarin’s gene therapy for hemophilia is a major win, but patient uptake could be slow. [ad_2] Source link
As the U.S. Gets Older, Some ETFs Bet on Aging in Place
[ad_1] A number of thematic funds are focused on companies that help seniors who want to stay in their homes as long as possible. [ad_2] Source link